Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Piperacillin Sodium and Tazobactam Sodium for Injection(4:1)

Approval Number

国药准字H20110063

Company珠海联邦制药股份有限公司中山分公司

Registration Date

March 13, 2020

Drug Information

Generic Name

注射用哌拉西林钠他唑巴坦钠(4:1)

Brand Name

美卓乐

Dosage Form

注射剂

Strength

1.25g(C23H27N5O7S 1.0g与C10H12N4O5S 0.25g)

Drug Type

化学药品

Registration Date

March 13, 2020

Company Information

Applicant Company

Company Name珠海联邦制药股份有限公司中山分公司

Manufacturing Company

Company Name珠海联邦制药股份有限公司中山分公司

Company Address

广东省中山市坦洲镇嘉联路12号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

注射用哌拉西林钠他唑巴坦钠(4:1) - NMPA 批准文号 | MedPath